Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Recent developments have set the stage for immunotherapy as a supplement to conventional cancer treatment. Consequently, a significant effort is required to further improve efficacy and specificity, particularly the identification of optimal therapeutic targets for clinical testing. Cancer/testis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gjerstorff, Morten F., Andersen, Mads H., Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599236/
https://www.ncbi.nlm.nih.gov/pubmed/26158218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599236/
https://www.ncbi.nlm.nih.gov/pubmed/26158218

Ejemplares similares